Filing Details
- Accession Number:
- 0001127602-24-008121
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-03-04 16:16:00
- Reporting Period:
- 2024-02-29
- Accepted Time:
- 2024-03-04 16:16:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885590 | Bausch Health Companies Inc. | BHC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1923756 | Seana Carson | 400 Somerset Corporate Boulevard Bridgewater NJ 08807 | Evp, General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares, No Par Value | Acquisiton | 2024-02-29 | 147,536 | $0.00 | 530,461 | No | 4 | A | Direct | |
| Common Shares, No Par Value | Disposition | 2024-03-01 | 765 | $9.89 | 529,696 | No | 4 | F | Direct | |
| Common Shares, No Par Value | Disposition | 2024-03-01 | 5,994 | $9.89 | 523,702 | No | 4 | F | Direct | |
| Common Shares, No Par Value | Disposition | 2024-03-01 | 16,973 | $9.89 | 506,729 | No | 4 | F | Direct | |
| Common Shares, No Par Value | Disposition | 2024-03-01 | 511 | $9.89 | 506,218 | No | 4 | F | Direct | |
| Common Shares, No Par Value | Disposition | 2024-03-04 | 4,420 | $9.80 | 501,798 | No | 4 | S | Direct | |
| Common Shares, No Par Value | Disposition | 2024-03-04 | 199 | $9.80 | 501,599 | No | 4 | S | Direct | |
| Common Shares, No Par Value | Disposition | 2024-03-04 | 1,561 | $9.80 | 500,038 | No | 4 | S | Direct | |
| Common Shares, No Par Value | Disposition | 2024-03-04 | 133 | $9.80 | 499,905 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.
- This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
- Represents shares of common stock sold in the open market pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on November 6, 2023.
Billionaire Hedge Funds
